生物活性 | |||
---|---|---|---|
描述 | LRH1 (liver receptor homologue-1; NR5A2) belongs to the four-member NR5A, or Ftz-F1, subfamily V of nuclear receptors. LRH1 regulates expression of Cyp19 (aromatase) and promotes motility and invasiveness in ER-positive breast cancer cells, suggesting LRH1 as a target for inverse agonists for the treatment of ER-positive breast cancers. ML-180 is an effective antagonist of LRH1 with an IC50 value of 3.7 μM[3]. In granulosa cells from superstimulated immature CON mice, ML-180 (3 µM; 6 hr) caused a demonstrable reduction in transcripts for Ccnd1, Ccnd2, Ccne1, and E2f1. At 24 hours of treatment, proliferation was suppressed by one-half[4]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.57mL 0.51mL 0.26mL |
12.86mL 2.57mL 1.29mL |
25.71mL 5.14mL 2.57mL |
参考文献 |
---|
[1]Busby S, et al. Discovery of Inverse Agonists for the Liver Receptor Homologue-1 (LRH1; NR5A2). |